Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Richard Law upgraded Rocket Pharmaceuticals Inc (NASDAQ:RCKT) from Sell to Neutral and raised the price target from $3 to $4. Rocket Pharmaceuticals closed at $2.54 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Jeffrey D. Hammond upgraded Generac Holdings Inc (NYSE:GNRC) from Sector Weight to Overweight and announced a $280 price target. Generac shares closed at $221.34 on Wednesday. See how other analysts view this stock.
- Goldman Sachs analyst Gabriela Borges upgraded Palantir Technologies Inc (NASDAQ:PLTR) from Neutral to Buy and announced a $230 price target. Palantir closed at $194.12 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Rayna Kumar upgraded Global Payments Inc (NYSE:GPN) from Perform to Outperform and announced a $115 price target. Global Payments shares closed at $81.08 on Wednesday. See how other analysts view this stock.
- Raymond James analyst Andrew Marok upgraded Unity Software Inc (NYSE:U) from Market Perform to Outperform and announced a $54 price target. Unity Software closed at $45.44 on Wednesday. See how other analysts view this stock.
Considering buying PLTR stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment